BioCentury
ARTICLE | Clinical News

Therakos Cellex photopheresis system regulatory update

March 30, 2009 7:00 AM UTC

FDA approved a PMA from Johnson & Johnson's Therakos Inc. subsidiary for its Therakos Cellex Photopheresis System for the palliative treatment of skin manifestations of cutaneous T cell lymphoma (CTC...